Prediction of progression to muscle-invasive disease in patients with high-risk bladder cancer

Affiliations

Editorial

Maciej Oszczudlowski et al. Transl Androl Urol. 2018 Aug.

. 2018 Aug;7(4):749-751.

doi: 10.21037/tau.2018.06.14.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool.
D Andrea D, Abufaraj M, Susani M, Ristl R, Foerster B, Kimura S, Mari A, Soria F, Briganti A, Karakiewicz PI, Gust KM, Rouprêt M, Shariat SF. D Andrea D, et al. Urol Oncol. 2018 May;36(5):239.e1-239.e7. doi: 10.1016/j.urolonc.2018.01.018. Epub 2018 Mar 3. Urol Oncol. 2018. PMID: 29506941

1. Cambier S, Sylvester RJ, Collette L, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin. Eur Urol 2016;69:60-9. 10.1016/j.eururo.2015.06.045 - DOI - PubMed
1. van den Bosch S, Witjes JA. Long-term Cancer-specific Survival in Patients with High-risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review. Eur Urol 2011;60:493-500. 10.1016/j.eururo.2011.05.045 - DOI - PubMed
1. Babjuk M, Bohle A, Burger M, et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61. 10.1016/j.eururo.2016.05.041 - DOI - PubMed
1. Sylvester RJ, van der Meijden APM, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77. 10.1016/j.eururo.2005.12.031 - DOI - PubMed
1. Kim HS, Kim M, Jeong CW, et al. Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: A systematic review and meta-analysis. Urol Oncol 2014;32:1191-9. 10.1016/j.urolonc.2014.05.008 - DOI - PubMed